Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ping-Ying Pan

Showing results (1-10 of 43) with videos related to

Pageof 5
Sort By:
Molecular Therapy. Oncology|June 18, 2025
The safer effector cell? Potential of CD147 CAR NK cells to tackle tumors with lower toxicityAlan Hodges, Shu-Hsia Chen, Ping-Ying Pan
Oncolytic Virotherapy|March 14, 2015
Immune cells: more than simple carriers for systemic delivery of oncolytic virusesSamuel Eisenstein, Shu-Hsia Chen, Ping-Ying Pan
Oncoimmunology|October 2, 2013
Myeloid-derived suppressor cells as a Trojan horse: A cellular vehicle for the delivery of oncolytic virusesPing-Ying Pan, Hui-Ming Chen, Shu-Hsia Chen
Advanced Drug Delivery Reviews|November 3, 2007
Advancements in immune tolerancePing-Ying Pan, Junko Ozao, Zuping Zhou, et al.
Biomarker Research|December 19, 2024
The LILRB family in hematologic malignancies: prognostic associations, mechanistic considerations, and therapeutic implicationsAlan Hodges, Rachel Dubuque, Shu-Hsia Chen, et al.
Cellular Immunology|February 14, 2021
Myeloid-derived suppressor cells as cellular immunotherapy in transplantation and autoimmune diseasesJilu Zhang, Alan Hodges, Shu-Hsia Chen, et al.
Journal of Molecular Cell Biology|March 28, 2013
Polarization and reprogramming of myeloid-derived suppressor cellsWen-Chin Yang, Ge Ma, Shu-Hsia Chen, et al.
Frontiers in Immunology|September 28, 2020
Analyzing One Cell at a TIME: Analysis of Myeloid Cell Contributions in the Tumor Immune MicroenvironmentVitaliy Davidov, Garrett Jensen, Sunny Mai, et al.
Cancer Research|February 12, 2004
Role of immature myeloid Gr-1+ cells in the development of antitumor immunityQingsheng Li, Ping-Ying Pan, Peidi Gu, et al.
Frontiers in Immunology|February 18, 2021
Corrigendum: Analyzing One Cell at a TIME: Analysis of Myeloid Cell Contributions in the Tumor Immune MicroenvironmentVitaliy Davidov, Garrett Jensen, Sunny Mai, et al.
Pageof 5

Showing results (1-10 of 43) with videos related to

Sort By:
Pageof 5
Molecular Therapy. Oncology|June 18, 2025
The safer effector cell? Potential of CD147 CAR NK cells to tackle tumors with lower toxicityAlan Hodges, Shu-Hsia Chen, Ping-Ying Pan
Oncolytic Virotherapy|March 14, 2015
Immune cells: more than simple carriers for systemic delivery of oncolytic virusesSamuel Eisenstein, Shu-Hsia Chen, Ping-Ying Pan
Oncoimmunology|October 2, 2013
Myeloid-derived suppressor cells as a Trojan horse: A cellular vehicle for the delivery of oncolytic virusesPing-Ying Pan, Hui-Ming Chen, Shu-Hsia Chen
Advanced Drug Delivery Reviews|November 3, 2007
Advancements in immune tolerancePing-Ying Pan, Junko Ozao, Zuping Zhou, et al.
Biomarker Research|December 19, 2024
The LILRB family in hematologic malignancies: prognostic associations, mechanistic considerations, and therapeutic implicationsAlan Hodges, Rachel Dubuque, Shu-Hsia Chen, et al.
Cellular Immunology|February 14, 2021
Myeloid-derived suppressor cells as cellular immunotherapy in transplantation and autoimmune diseasesJilu Zhang, Alan Hodges, Shu-Hsia Chen, et al.
Journal of Molecular Cell Biology|March 28, 2013
Polarization and reprogramming of myeloid-derived suppressor cellsWen-Chin Yang, Ge Ma, Shu-Hsia Chen, et al.
Frontiers in Immunology|September 28, 2020
Analyzing One Cell at a TIME: Analysis of Myeloid Cell Contributions in the Tumor Immune MicroenvironmentVitaliy Davidov, Garrett Jensen, Sunny Mai, et al.
Cancer Research|February 12, 2004
Role of immature myeloid Gr-1+ cells in the development of antitumor immunityQingsheng Li, Ping-Ying Pan, Peidi Gu, et al.
Frontiers in Immunology|February 18, 2021
Corrigendum: Analyzing One Cell at a TIME: Analysis of Myeloid Cell Contributions in the Tumor Immune MicroenvironmentVitaliy Davidov, Garrett Jensen, Sunny Mai, et al.
Pageof 5